Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
73.15
-0.66 (-0.89%)
Nov 22, 2024, 4:00 PM EST - Market closed
Insmed Revenue
Insmed had revenue of $93.43M in the quarter ending September 30, 2024, with 18.15% growth. This brings the company's revenue in the last twelve months to $342.96M, up 22.13% year-over-year. In the year 2023, Insmed had annual revenue of $305.21M with 24.39% growth.
Revenue (ttm)
$342.96M
Revenue Growth
+22.13%
P/S Ratio
33.16
Revenue / Employee
$376,050
Employees
912
Market Cap
13.09B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 305.21M | 59.85M | 24.39% |
Dec 31, 2022 | 245.36M | 56.90M | 30.19% |
Dec 31, 2021 | 188.46M | 24.05M | 14.63% |
Dec 31, 2020 | 164.41M | 27.95M | 20.48% |
Dec 31, 2019 | 136.47M | 126.63M | 1,287.56% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fresenius Medical Care AG | 21.46B |
Tenet Healthcare | 20.97B |
Universal Health Services | 15.42B |
DaVita | 12.67B |
Solventum | 8.22B |
Incyte | 4.08B |
Genmab | 2.97B |
BioMarin Pharmaceutical | 2.75B |
INSM News
- 4 days ago - Insmed: PAH Treatment Advancement With 2nd Half 2025 Top-Line Data - Seeking Alpha
- 17 days ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 18 days ago - Insmed To Present at November 2024 Investor Conferences - PRNewsWire
- 24 days ago - Insmed Incorporated (INSM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update - PRNewsWire
- 4 weeks ago - Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List - PRNewsWire
- 4 weeks ago - Insmed Unites Across Communities Around the World During Third Annual Global Day of Good - PRNewsWire
- 5 weeks ago - Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024 - PRNewsWire